Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by mercedesmanon Oct 02, 2024 1:46pm
73 Views
Post# 36250313

RE:RE:RE:RE:RE:RE:Rivemont Presentation Video

RE:RE:RE:RE:RE:RE:Rivemont Presentation Video

Right

$1 today is about as good as $2 , 5 plus years from now, depending on your discount rate. 

Might be a stretch to hope for a $1 offer while trading at .35

If MBX can string together a couple of good qtrs ( fingers crossed on QDEL and maybe a largish VTM order or two)  then maybe it can scratch and claw its way to .50 ... at which point a buck offer could be on the table. 

The Kinlytic piece is the hard part to swallow. The analyst is only valuing it at $50M I believe ( in their target price) - a mere fraction of its future value if everything came to fruition. A potential buyer will also be eyeing the juicy future cash flow potential, but then has to discount it for the next 3-5 years and then factor in the risk of non approval or market acceptance. 


MM 

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse